BSECompany Update2 Nov 2026 · 2 Nov 2026, 08:18 pm

Reappointment of Dr. Hardik Joshipura as MD & CEO of the Company for a further term of three years commencing from February 12, 2027, to February 11, 2030, subject to approval of the shareholders of the company.

Innovassynth Technologies (India) Ltd · 533315

✦ AI SummaryMgmt Change

Innovassynth Technologies (India) Ltd has announced the reappointment of Dr. Hardik Joshipura as Managing Director & CEO for a further term of three years, subject to shareholder approval.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Innovassynth Technologies (India) Ltd - 533315 - Announcement under Regulation 30 (LODR)-Change in Directorate

Attachments (1)

📄

07aaddba-6d90-4627-9942-85eb3c6706c8.pdf

pdf

Download →
View document text
Date: November 2, 2026 Manager, Corporate Relationship Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Scrip Code: 533315 Subject: Intimation regarding re-appointment of Managing Director & CEO pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e., Monday, November 02, 2026, based on the recommendation of the Nomination and Remuneration Committee, has considered and approved the re-appointment of Dr. Hardik Joshipura as the Managing Director & CEO of the Company for a further term of three (3) years commencing from February 12, 2027, to February 11, 2030 (both days inclusive), liable to retire by rotation, on the terms and conditions recommended by the Nomination and Remuneration Committee, subject to the approval of the shareholders of the Company. The requisite details pursuant to Regulation 30 of the Listing Regulations read with Annexure 18 of Chapter V, Section V-A of the SEBI Master Circular dated January 30, 2026, are enclosed herewith as Annexure A. Kindly take the above on your records and acknowledge receipt. Thanking You, Yours faithfully, For INNOVASSYNTH TECHNOLOGIES (INDIA) LIMITED (Formerly known as Innovassynth Investments Limited) Sameer Salim Pakhali Company Secretary & Compliance Officer ACS 55746 Innovassynth Technologies (India) Limited (Formerly, Innovassynth Investments Limited) Registered office: Corporate Office: Old Mumbai–Pune Road, TCG International Biotech Park, Khopoli – 410 203 India. 2nd Floor, Genesis Square, Phone: +91–2192–260100 Hinjewadi Phase – II, Email: itil@innovassynth.com Pune – 411 057, India. CIN: L67120MH2008PLC178923 Phone: +91–20–61921000 www.innovassynth.com Annexure A 1 Reasons for Change viz. Re-appointment of Dr. Hardik Joshipura as Appointment /Re-appointment, Managing Director & CEO upon completion resignation, removal, death or of his existing tenure. otherwise 2 Date of appointment/re- Approved by the Board on November 02, appointment & Term of 2026, with effect from February 12, 2027 appointment/re-appointment (both days inclusive), subject to shareholders' approval. Re-appointed for a further term of three (3) years commencing February 12, 2027, to February 11, 2030. Dr. Hardik Joshipura shall be liable to retire by rotation. 3 Brief profile Dr. Hardik Joshipura serves as the Managing Director & CEO of the company. Before joining Innovassynth, he held various senior leadership positions at Sigma-Aldrich and later at Merck KGaA, gaining extensive experience in manufacturing, sales, and global strategic marketing. Dr. Joshipura began his career at Zydus Cadila, where he led Contract Research R&D for the Fine Chemicals business. He holds a Ph.D. in Organic Chemistry and is an alumnus of Harvard Business School (HBS), Boston, USA, where he completed Executive MBA. 4 Disclosure of Relationships Dr. Hardik Joshipura is not related to any between Directors Directors or Key Managerial Personnel of the Company. 5 Other Directorships / Not applicable Memberships (in listed entities in case of resignation of independent director) 6 Other details Dr. Hardik Joshipura is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority, as applicable. Innovassynth Technologies (India) Limited (Formerly, Innovassynth Investments Limited) Registered office: Corporate Office: Old Mumbai–Pune Road, TCG International Biotech Park, Khopoli – 410 203 India. 2nd Floor, Genesis Square, Phone: +91–2192–260100 Hinjewadi Phase – II, Email: itil@innovassynth.com Pune – 411 057, India. CIN: L67120MH2008PLC178923 Phone: +91–20–61921000 www.innovassynth.com